Faculty Viewpoints
The Digital Tool That Helps Robert Shiller Understand the Past
We asked the Nobel Prize-winning Yale economist to reflect on an unexpected source of research information and inspiration. He writes that Google Ngram Viewer can provide important insights about how people saw economic events as they unfolded.
Office Romance Policies Aren’t Working
Yale SOM leadership expert Jeffrey Sonnenfeld and author Joanne Lipman write that Jeff Zucker's departure from CNN illustrates the inconsistency and ambiguity of corporate policies on workplace relationships.
Health & Veritas: Is Long COVID One Disease or Many?
On the Health & Veritas podcast, Yale physician-professors Howard Forman and Harlan Krumholz talk with Dr. Akiko Iwasaki about her research trying to understand the cause or causes of long COVID, which has more than 200 reported symptoms.
To Be More Charismatic, Take the Focus off Yourself
In an excerpt from her book Influence Is Your Superpower, Yale SOM's Zoe Chance explains how to avoid “anti-charismatic” behaviors that we fall back on when we’re feeling powerless, including overusing personal pronouns and adding unnecessary apologies and caveats.
Health & Veritas: Medical Storytelling
On the latest episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz discuss two recent studies (one of them co-authored by Harlan) illustrating the health impacts of racism. Then they’re joined by Randi Epstein, a physician and journalist whose most recent book is Aroused: The History of Hormones and How They Control Just About Everything.
Health & Veritas: Genomic Surveillance
On the latest episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz are joined by Yale epidemiologist Nathan Grubaugh. They discuss the utility of rapid antigen tests and Grubaugh’s work tracking the evolution of COVID-19 variants.
Health & Veritas: From COVID or with COVID?
On the latest episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz talk about the patients who test positive for COVID-19 after being admitted to the hospital for something else, and other health issues in the news, including the explosion in healthcare spending last year, a controversial Alzheimer’s drug, and the consequences of underinsurance in the United States.
Beyond Resolutions: Research-Based Suggestions for 2022
We asked faculty from the Yale School of Management for their advice—philosophical, professional, and personal—for our readers for the coming year.
Health & Veritas: The Latest on Omicron
On the latest episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz discuss the state of the omicron surge and what we know and don’t know about the variant. Then they’re joined by Yale scientist Anne Wyllie, whose new research casts doubt on the ability of rapid antigen tests to detect asymptomatic omicron infections.
A Year Later, Most CEOs Are Keeping Their Post-Insurrection Promises
Recent news stories have asserted that corporate leaders are reneging on their pledges to withhold contributions to members of Congress who voted against certifying election results on January 6, 2021. But Yale SOM's Jeffrey Sonnenfeld, who hosted one of the meetings where those pledges were made, writes that CEOs remain deeply troubled by threats to democracy, and that campaign records show that most corporate PACs aren't giving to election objectors.
